Printer Friendly

Asymmetry Capital Management welcomes James Yin, PhD to team.

M2 EQUITYBITES-February 13, 2018-Asymmetry Capital Management welcomes James Yin, PhD to team

(C)2018 M2 COMMUNICATIONS http://www.m2.com

Asset management firm Asymmetry Capital Management LP reported on Monday the addition of James Yin, PhD to the Asymmetry Investment Team.

Based in the company's San Francisco headquarters, Dr Yin will work as an analyst covering global therapeutics.

The Asymmetry team has over 42-years combined healthcare and healthcare investing experience across market cycles and macro events.

Previously, Dr Yin has conducted research at the National Institutes of Health (NIH) and the University of Minnesota where he participated in breakthrough research to solve the atomic structure of the Rous Sarcoma Virus Intasome. This research was published in the Journal Nature in February 2016.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Feb 13, 2018
Words:133
Previous Article:Jyske Bank reports on share repurchase programme.
Next Article:Kinnevik announces grant of 200,000 call options to CEO.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters